Good morning :)
Place Order
Add to Watchlist

Jubilant Ingrevia Ltd

JUBLINGREA

Jubilant Ingrevia Ltd

JUBLINGREA
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹10,848 cr, stock is ranked 468
High RiskStock is 3.47x as volatile as Nifty
686.154.23% (+27.85)
686.154.23% (+27.85)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹10,848 cr, stock is ranked 468
High RiskStock is 3.47x as volatile as Nifty

How to use scorecard? Learn more

MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹10,848 cr, stock is ranked 468
High RiskStock is 3.47x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
52.573.960.73%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
28.213.211.48%

Forecast & Ratings

Detailed Forecast 
67%
Analysts have suggested that investors can buy this stock

from 3 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Jubilant Ingrevia is engaged in the business of integrated life science products.

Investor Presentation

View older 

Feb 28, 2025

PDF
View Older Presentations
PE Ratio
94.22
1Y Return
5.47%
Buy Reco %
80.00
PE Ratio
74.75
1Y Return
33.26%
Buy Reco %
76.00
PE Ratio
51.83
1Y Return
1.12%
Buy Reco %
53.85
PE Ratio
35.12
1Y Return
36.00%
Buy Reco %
50.00
PE Ratio
35.37
1Y Return
38.94%
Buy Reco %
58.82
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue0.00686.734,980.854,806.064,171.124,239.84
Raw Materialssubtract0.00379.462,984.962,709.312,089.453,737.35
Power & Fuel Costsubtract0.0051.71468.23722.83539.98
Employee Costsubtract0.0049.02327.28343.48383.95
Selling & Administrative Expensessubtract0.1734.41208.60271.70358.69
Operating & Other expensessubtract0.0065.35128.52178.26342.62
Depreciation/Amortizationsubtract0.0022.06123.39122.18136.17153.96
Interest & Other Itemssubtract0.007.3330.9421.5852.6655.35
Taxes & Other Itemssubtract0.0023.03232.23129.2284.7286.81
EPS-3.406.8029.9619.3211.4812.96
DPS0.000.355.005.005.005.00
Payout ratio0.000.050.170.260.440.39

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual report

PDF

Investor Presentation

Mar 29PDF
Mar 28PDF
Oct 19PDF
+3 more
FY 2023

Annual report

PDF

Investor Presentation

Nov 7PDF
Aug 16PDF
Jul 4PDF
FY 2025

Annual Report Pending

Investor Presentation

Feb 28PDF
 

Peers & Comparison

Comparing 3 stocks from 
MaterialsSpecialty Chemicals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Jubilant Ingrevia Ltd59.323.960.73%
Gujarat Fluorochemicals Ltd94.226.900.08%
Navin Fluorine International Ltd74.758.490.37%
Vinati Organics Ltd51.836.800.43%

Price Comparison

Compare JUBLINGREA with any stock or ETF
Compare JUBLINGREA with any stock or ETF
JUBLINGREA
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding51.47%13.91%2.08%6.89%25.64%

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Shareholding History

SepDec '23MarJunSepDec '246.30%6.35%6.58%6.55%7.22%6.89%

Mutual Funds Holding Trend

Increased Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 1.19%

Top 5 Mutual Funds holding Jubilant Ingrevia Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
5.0983%3.69%-0.13%2/79 (0)
2.8708%1.75%-0.07%24/62 (-2)
0.9148%2.38%-0.18%51/87 (-1)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateFeb 3, 2025

Interim
Interim | Div/Share: ₹2.50

Dividend/Share

2.50

Ex DateEx Date

Feb 3, 2025

Cash Dividend

Ex DateEx DateAug 2, 2024

Final
Final | Div/Share: ₹2.50

Dividend/Share

2.50

Ex DateEx Date

Aug 2, 2024

Cash Dividend

Ex DateEx DateFeb 9, 2024

Interim
Interim | Div/Share: ₹2.50

Dividend/Share

2.50

Ex DateEx Date

Feb 9, 2024

Cash Dividend

Ex DateEx DateAug 10, 2023

Final
Final | Div/Share: ₹2.50

Dividend/Share

2.50

Ex DateEx Date

Aug 10, 2023

Cash Dividend

Ex DateEx DateFeb 10, 2023

Interim
Interim | Div/Share: ₹2.50

Dividend/Share

2.50

Ex DateEx Date

Feb 10, 2023

News & Opinions
Earnings
Jubilant Ingrevia consolidated net profit rises 79.93% in the December 2024 quarter

Net profit of Jubilant Ingrevia rose 79.93% to Rs 69.38 crore in the quarter ended December 2024 as against Rs 38.56 crore during the previous quarter ended December 2023. Sales rose 8.91% to Rs 1046.06 crore in the quarter ended December 2024 as against Rs 960.45 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales1046.06960.45 9 OPM %13.229.95 - PBDT135.3489.32 52 PBT95.5855.08 74 NP69.3838.56 80 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Jubilant Ingrevia fixes record date for interim dividend

Jubilant Ingrevia has fixed 03 February 2025 as record date for the purpose of ascertaining eligibility of the shareholders for payment of interim dividend. The dividend will be paid on or before 26 February 2025. Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Board of Jubilant Ingrevia recommends Interim Dividend

Jubilant Ingrevia announced that the Board of Directors of the Company at its meeting held on 28 January 2025, has recommended a Interim dividend of Rs.2.50 per share (i.e.250%), subject to the approval of the shareholders.Powered by Capital Market - Live

1 month agoCapital Market - Live
Spotlight
Jubilant Ingrevia commissions new cGMP facility for supplying Niacinamide to global clients

The new facility, which has a capacity of 5,000 metric tonnes, will manufacture nutraceuticals and dietary-active ingredients for human consumption. The facility is an extension of the company's US FDA approved plant that is already supplying to the U.S., Europe, Japan and many other markets. The Niacinamide from the new plant in addition to its various applications in skin and hair care, will also pave way for the company to foray into infant nutrition market globally, with food grade Niacin. The production of these new grades of Vitamin B3 will significantly enhance the company's presence within value-added products with this high-value and high-margin offering. Deepak Jain, CEO & managing director, Jubilant Ingrevia said: 'The commissioning of our new facility for Niacinamide aimed at food, nutrition and cosmetic applications is an important milestone in our journey. We are already one of the world's largest producers of Niacinamide and as we ramp up the utilisation of this new plant, we aim to become global leader in Vitamin B3 in the coming years. With this, we are now among a select few capable of producing high-quality Vitamin B3 for these high-value, high margin offerings. It also gives us a strategic moat, protecting us from industry volatility in feed-grade Niacinamide. We are pleased to share that we are already in discussions with some of the most recognizable global brands to begin our supplies. Jubilant Ingrevia is a global integrated life science products and innovative solutions provider serving, pharmaceutical, nutrition, agrochemical, consumer and industrial customers with its customised products and solutions that are innovative, cost effective and conforming to premium quality standards. The company is engaged in manufacturing and supply of speciality chemicals, nutrition & health solutions and chemical intermediates through five manufacturing facilities in India. The company's consolidated net profit rose 2.63% to Rs 59 crore on 1.77% increase in revenue to Rs 1029 crore in Q2 FY25 as compared with Q2 FY24. The scrip fell 1.94% to currently trade at Rs 674.05 on the BSE. Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Jubilant Ingrevia commissions new cGMP compliant facility at Bharuch, Gujarat

Jubilant Ingrevia today announced the commissioning of its new cGMP compliant facility at Bharuch, Gujarat. The new facility will manufacture Nutraceuticals and Dietary-Active ingredients for human consumption. The facility is an extension of the company's USFDA approved plant that is already supplying to the U.S., Europe, Japan and many other markets. It will be fully equipped to cater to the needs of the biggest marquee customers in the food, nutrition and cosmetics space. Customers seeking greener supply chains and high bio-content in their inputs, will especially stand to benefit. The Niacinamide from the new plant in addition to its various applications in skin and hair care, will also pave way for the Company to foray into infant nutrition market globally, with food grade Niacin. The production of these new grades of Vitamin B3 will significantly enhance the Company's presence within value-added products with this high-value and high-margin offering. Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Jubilant Ingrevia to hold board meeting

Jubilant Ingrevia will hold a meeting of the Board of Directors of the Company on 28 January 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Live Market Update
Nifty hovers below 23,550 mark; realty shares decline

The key equity indices continued to trade in negative terrain with significant losses in the morning trade. The Nifty hovered below the 23,550 mark. Realty shares extended losses for the third consecutive trading session. At 10:30 IST, the barometer index, the S&P BSE Sensex, declined 483.03 points or 0.62% to 77,765.10. The Nifty 50 index dropped 121.65 points or 0.51% to 23,523.25. In the broader market, the S&P BSE Mid-Cap index fell 0.78% and the S&P BSE Small-Cap index declined 0.33%. The market breadth was negative. On the BSE, 1,554 shares rose and 2,020 shares fell. A total of 156 shares were unchanged. New Listing: Shares of Unimech Aerospace and Manufacturing were currently trading at Rs 1,375.85 at 10:18 IST on the BSE, representing a premium of 75.27% as compared with the issue price of Rs 785. The scrip was listed at Rs 1,491, exhibiting a premium of 89.94% to the issue price. So far, the stock has hit a high of 1,491 and a low of 1,355.05. On the BSE, over 4.21 lakh shares of the company were traded in the counter so far. Buzzing Index: The Nifty Realty index lost 0.77% to 1,046.75. The index fell 2.83% in three consecutive trading sessions. Macrotech Developers (down 4.42%), Phoenix Mills (down 2.61%) and Godrej Properties (down 2.14%) declined. On the other hand, Prestige Estates Projects (up 1.11%), Brigade Enterprises (up 0.60%) and Mahindra Lifespace Developers (up 0.59%) edged higher. Stocks in Spotlight: Jubilant Ingrevia advanced 2.64% after the company's wholly owned subsidiary, Jubilant Infrastructure (JIL) board has approved to purchase 6.67% stake in Forum I Aviation Private (FAPL) from Hero Fincorp & Sunil Kant Munjal. KPI Green Energy rose 0.21%. The company said that it has obtained approvals from the chief electrical inspector (CEIG) for 28.28 MW of solar power projects under CPP business segment.Powered by Capital Market - Live

2 months agoCapital Market - Live
Spotlight
Jubilant Ingrevia rises after arm plans to acquire 7% stake in FAPL

FAPL is engaged in business of operating aircrafts on charter basis under the non-scheduled airlines. It revenue was Rs 27.32 crore in FY24. The purpose of making further investment by Jubilant Infrastructure in FAPL is to meet business requirements. The company will acquire 16.67% at Rs 10.2915 per share. The said transaction is expected to be completed within this financial year. At present JIL holds 9.12% equity shares in FAPL. Post-acquisition, JIL holds 15.79% equity shares in FAPL Jubilant Ingrevia is a global integrated life science products and innovative solutions provider serving, pharmaceutical, nutrition, agrochemical, consumer and industrial customers with its customised products and solutions that are innovative, cost effective and conforming to premium quality standards. The company is engaged in manufacturing and supply of speciality chemicals, nutrition & health solutions and chemical intermediates through five manufacturing facilities in India. The company's consolidated net profit rose 2.6% to Rs 59 crore on 1.8% increase in net sales to Rs 1029 crore in Q2 FY25 over Q2 FY24.Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Jubilant Ingrevia issues commercial paper of Rs 48 cr

Jubilant Ingrevia has issued commercial paper of Rs 48 crore on 27 December 2024. Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Jubilant Ingrevia consolidated net profit rises 2.63% in the September 2024 quarter

Net profit of Jubilant Ingrevia rose 2.63% to Rs 59.00 crore in the quarter ended September 2024 as against Rs 57.49 crore during the previous quarter ended September 2023. Sales rose 1.77% to Rs 1029.00 crore in the quarter ended September 2024 as against Rs 1011.10 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1029.001011.10 2 OPM %12.0911.64 - PBDT119.82113.78 5 PBT80.2279.87 0 NP59.0057.49 3 Powered by Capital Market - Live

4 months agoCapital Market - Live

Frequently asked questions

  1. What is the share price of Jubilant Ingrevia Ltd (JUBLINGREA) today?

    The share price of JUBLINGREA as on 7th March 2025 is ₹686.15. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Jubilant Ingrevia Ltd (JUBLINGREA) share?

    The past returns of Jubilant Ingrevia Ltd (JUBLINGREA) share are
    • Past 1 week: 3.31%
    • Past 1 month: -9.13%
    • Past 3 months: -10.58%
    • Past 6 months: -2.29%
    • Past 1 year: 45.17%
    • Past 3 years: 59.66%
    • Past 5 years: 155.36%

  3. What are the peers or stocks similar to Jubilant Ingrevia Ltd (JUBLINGREA)?
  4. What is the dividend yield % of Jubilant Ingrevia Ltd (JUBLINGREA) share?

    The current dividend yield of Jubilant Ingrevia Ltd (JUBLINGREA) is 0.73.

  5. What is the market cap of Jubilant Ingrevia Ltd (JUBLINGREA) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Jubilant Ingrevia Ltd (JUBLINGREA) is ₹10848.32 Cr as of 7th March 2025.

  6. What is the 52 week high and low of Jubilant Ingrevia Ltd (JUBLINGREA) share?

    The 52-week high of Jubilant Ingrevia Ltd (JUBLINGREA) is ₹885 and the 52-week low is ₹422.

  7. What is the PE and PB ratio of Jubilant Ingrevia Ltd (JUBLINGREA) stock?

    The P/E (price-to-earnings) ratio of Jubilant Ingrevia Ltd (JUBLINGREA) is 59.32. The P/B (price-to-book) ratio is 3.96.

  8. Which sector does Jubilant Ingrevia Ltd (JUBLINGREA) belong to?

    Jubilant Ingrevia Ltd (JUBLINGREA) belongs to the Materials sector & Specialty Chemicals sub-sector.

  9. How to buy Jubilant Ingrevia Ltd (JUBLINGREA) shares?

    You can directly buy Jubilant Ingrevia Ltd (JUBLINGREA) shares on Tickertape. Simply sign up, connect your demat account and place your order.